The big picture: Walmart is significantly expanding its employee health benefits in 2027, offering free GLP-1 medications and over 250 other prescription drugs, alongside enhanced specialized medical care.

Why it matters: This move by the nation's largest private employer highlights a growing trend of companies investing in comprehensive health benefits to attract and retain talent, even as healthcare costs rise.

Between the lines:

• Walmart will provide free GLP-1 drugs for Type 2 diabetes and certain insulin products and inhalers.
• The company is expanding its Centers of Excellence program for specialized care in conditions like MS and Parkinson's disease.
• Premiums for Walmart's starting health insurance plan will increase by $1.50 per biweekly pay period.

Staffing & HR impact: Such robust benefits packages can significantly boost employee retention and recruitment efforts, potentially reducing turnover costs and enhancing overall workforce well-being. HR departments will need to effectively communicate these complex changes to a large employee base.

The bottom line: Walmart's investment signals a strategic shift towards more comprehensive employee welfare, setting a potential benchmark for other large employers.